Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center

BACKGROUND: Iodine-125 low-dose-rate brachytherapy (LDR-BT) is a treatment modality utilized in both localized and advanced prostate cancer (PCa). We aimed to evaluate the long-term oncological outcomes in patients with PCa who underwent LDR-BT, at a single institution in Japan. METHODS: We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Shinichi, Iinuma, Koji, Nakano, Masahiro, Kawase, Makoto, Kato, Daiki, Kawase, Kota, Takai, Manabu, Nakane, Keita, Ito, Masaya, Kumano, Tomoyasu, Matsuo, Masayuki, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747569/
https://www.ncbi.nlm.nih.gov/pubmed/36570651
http://dx.doi.org/10.1016/j.prnil.2022.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747569/
https://www.ncbi.nlm.nih.gov/pubmed/36570651
http://dx.doi.org/10.1016/j.prnil.2022.05.003

Ejemplares similares